AgeX Therapeutics was a BioTime spinout pursuing cell-reprogramming and pluripotent stem-cell therapies for aging; it was reverse-merged into Serina Therapeutics in 2024 and its aging assets were sold to Juvenescence.
Biotech using cellular reprogramming to restore cell health and reverse aspects of aging, injury, and disease.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →